AVANCES EN PROBIÓTICOS, PREBIÓTICOS Y MICROBIOMA COMO ESTRATEGIA PREVENTIVA
Synopsis
Over the past decade, the study of the human microbiome has transformed our understanding of its relationship with host physiology. Advances in metagenomics and molecular biology demonstrate the role of probiotics, prebiotics, and synbiotics in the prevention of infectious, inflammatory, and metabolic diseases. These act by strengthening the intestinal barrier, modulating the immune response, and generating bioactive metabolites such as short-chain fatty acids. However, the heterogeneity of strains and dosages limits their clinical standardization. Objective: To analyze the scientific evidence (2020–2025) on the preventive effects, biological mechanisms, efficacy, and safety of probiotics, prebiotics, and synbiotics, as well as their applicability in preventive medicine. Methods: A narrative systematic review (PRISMA) was conducted in PubMed, Scopus, Web of Science, and the Cochrane Library, including randomized controlled trials, systematic reviews, and meta-analyses. Results: Multispecies probiotics (Lactobacillus and Bifidobacterium) significantly reduced antibiotic-associated diarrhea (RR=0.61; 95% CI 0.51-0.73). In older adults, synbiotics decreased respiratory infections and inflammatory markers (TNF-α, IL-6, IL-1β), and increased IL-10. Metabolically, they improved HOMA-IR, triglyceride, and butyrate levels, although there was no evidence of a positive effect on major cardiovascular events. Adverse effects were mild and transient. Conclusions: These interventions are effective and safe for infection prevention and immunometabolic modulation. International standardization, genetic traceability, and the development of precision probiotics supported by omics technologies and artificial intelligence are needed to advance toward personalized preventive medicine based on the microbiome.
Downloads
Volume
Pages
Published
Categories
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.